| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |